Mark Opler's guest appearances

Mark Opler

WCG Talks Trials

Steve Young

David Fajgenbaum

Scott Hunter

Kristin Smedley

Andrew Cutler

Leslie Citrome

Jeffrey Cooper

Bryce Olson

Linda Sullivan

Ken Getz

Nathaniel Katz

Karmen Trzupek

Brian Loew

Emil Kakkis

Amanda Moore

OwlTail

In this episode, Mark Opler, PhD, MPH, Chief Research Officer at WCG MedAvante-ProPhase sits down with Steve Smith, WCG’s President of Patient Advocacy to discuss the achievements in the field of CNS and rare disease clinical research. Dr. Opler and Steve highlight the unmet need of therapies available for rare disease, the importance of patient enrollment, ensuring efficacy and safety throughout a trial, and how time is of the essence in every study that is conducted. 

<p>In this episode, Mark Opler, PhD, MPH, Chief Research Officer at WCG MedAvante-ProPhase sits down with Steve Smith, WCG’s President of Patient Advocacy to discuss the achievements in the field of CNS and rare disease clinical research. Dr. Opler and Steve highlight the unmet need of therapies available for rare disease, the importance of patient enrollment, ensuring efficacy and safety throughout a trial, and how time is of the essence in every study that is conducted. </p>

Blazing New Trails in Rare Disease & CNS Clinical Studies: An Interview with Dr. Mark Opler